Advertisement
Home Tags Cancer: Lung

Tag: Cancer: Lung

The CYP3A7*1C allele appears to be associated with mortality and disease progression in specific cancers

CYP3A7*1C Allele Linked to Cancer Mortality, Progression

0
Associated with adverse outcomes in breast cancer, lung cancer, chronic lymphocytic leukemia
Xalkori (crizotinib) has been approved by the U.S. Food and Drug Administration to treat advanced non-small-cell lung cancer with tumors that have a rare ROS1 gene mutation.

FDA Approves Xalkori for Rare Genetic Form of Lung Cancer

0
Drug approval expanded to include patients with ROS1-positive NSCLC
Dietary glycemic index is associated with lung cancer risk

Dietary Glycemic Index Linked to Lung Cancer Risk

0
More pronounced link for never smokers, squamous cell carcinoma, those with <12 years education
Most lung cancer-specific tweets relate to support or prevention

Most Lung Cancer-Specific Tweets Relate to Support, Prevention

0
<20 percent of tweets about clinical trials; only one tweet linked to a patient recruitment website
Many lung and esophageal cancer survivors have positron emission tomography imaging scans as part of ongoing monitoring

PET Scans May Be Overused in Monitoring of Cancer Survivors

0
Study finds using costly test as first option for follow-up may not improve survival
Cola intake leads to a clinically relevant and statistically significant increase in the bioavailability of erlotinib during esomeprazole treatment

Cola Intake Increases Exposure of Erlotinib

0
Findings in patients treated with esomeprazole; likely due to pH-dependent solubility
For patients with early-stage small-cell lung cancer undergoing resection

Adjuvant Therapy Ups Survival in Small-Cell Lung Cancer

0
Improved survival for chemotherapy with or without cranial irradiation versus surgery alone
Lung cancer surgery patients who are either underweight or severely obese appear to have higher rates of complications and mortality following surgery

Weight Appears to Impact Outcomes Post Lung CA Surgery

0
Both underweight and very obese had the highest odds for complications
For patients with non-small-cell lung cancer with activating epidermal growth factor receptor mutations

Support for First-Line Erlotinib in NSCLC With EGFR Mutations

0
And erlotinib therapy beyond progression may delay salvage tx for some patients
Racial/ethnic variation is evident in lung cancer incidence and mortality among postmenopausal women

Modifiable Factors Affect Racial Differences in Lung Cancer

0
No racial/ethnic differences in the risk of lung cancer death among women in fully adjusted models